Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Vi-DT Conjugate Vaccine in Healthy Filipino Adults and Children
NCT02645032Phase 1Completed
- Sponsor
- International Vaccine Institute
- Start
- May 2016
- Primary completion
- Feb 2017
- Modality
- Vaccines & Immunotherapeutics
01
Overview
Phase 1, randomised, double-blind trial of typhoid conjugate vaccine in typhoid fever (2 arms), sponsored by International Vaccine Institute. Primary endpoint: Solicited Adverse Events and Serious Adverse Events. Started May 2016; status: completed.
02
Drugs
typhoid conjugate vaccine
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT02645032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02645032.